Endocrinology/Hormones
Endocrinology/hormone inhibitors are compounds that block the action of hormones or interfere with hormone signaling pathways. These inhibitors are essential for studying the regulation of endocrine systems and for developing treatments for hormone-related diseases, such as diabetes, thyroid disorders, and hormone-dependent cancers. By modulating hormone activity, these inhibitors can help elucidate the complex interactions within the endocrine system. At CymitQuimica, we offer a wide range of high-quality endocrinology/hormone inhibitors to support your research in endocrinology, pharmacology, and medical sciences.
Subcategories of "Endocrinology/Hormones"
- Androgen Receptor(211 products)
- Annexin A(11 products)
- Aromatase(20 products)
- Estrogen/progestogen Receptor(50 products)
- GPR(1 products)
- Glucocorticoid Receptor(154 products)
- LHRH(1 products)
- Opioid Receptor(298 products)
- Prostaglandin Receptor(120 products)
- RAAS(88 products)
- Reductase(52 products)
- Somatostatin(49 products)
- Thyroid hormone receptor(THR)(26 products)
- Vasopressin Receptor(45 products)
Show 6 more subcategories
Found 3193 products of "Endocrinology/Hormones"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
4'-hydroxy Tamoxifen
CAS:<p>It is a metabolite of tamoxifen and an estrogen receptor modulator.</p>Formula:C26H29NO2Purity:98%Color and Shape:SolidMolecular weight:387.51Angiotensin amide
CAS:<p>Angiotensin amide, an octapeptide amide, can be used to increase blood pressure by vasoconstriction.</p>Formula:C49H70N14O11Purity:98%Color and Shape:SolidMolecular weight:1031.17D3R/MOR antagonist 2
<p>Compound 121, a D3R/MOR antagonist with K i values of 361 nM and 85.2 nM for D3R and MOR respectively, has the potential for analgesic effects through MOR</p>Formula:C25H31ClN2OPurity:98%Color and Shape:SolidMolecular weight:410.98BigLEN(mouse)
CAS:<p>GPR171 agonist from ProSAAS controls mouse appetite, reduces glutamate in paraventricular neurons via G protein.</p>Formula:C78H130N24O22Purity:98%Color and Shape:SolidMolecular weight:1756.03UFP-101
CAS:<p>Strong, selective NOP receptor antagonist with pKi=10.24; >3000x selectivity over δ, μ, κ receptors; blocks nociceptin effects.</p>Formula:C82H138N32O21Purity:98%Color and Shape:SolidMolecular weight:1908.19ARD-2585
CAS:ARD-2585 is an orally active and selective androgen receptor PROTAC degrader with anticancer activity for the study of prostate cancer.Formula:C41H43ClN8O5Color and Shape:SolidMolecular weight:763.28PROTAC ER Degrader-4
CAS:<p>PROTAC ER Degrader-4 is a PROATC degrader of estrogen receptor (ER)(IC50 of 0.8 nM).</p>Formula:C53H67F3N6O8SPurity:98%Color and Shape:SolidMolecular weight:1005.2(rel)-PROTAC ERRα Degrader-1
(rel)-PROTAC ERRα Degrader-1 is a relative configuration of PROTAC ERRα Degrader-1, which is an estrogen-related receptor alpha (ERRa) degrader.Formula:C54H49Cl2F6N7O8Purity:98%Color and Shape:SolidMolecular weight:1108.91DAMGO (TFA)
CAS:DAMGO is a selective peptide agonist of the µ-opioid receptor .Formula:C28H36F3N5O8Purity:98%Color and Shape:SolidMolecular weight:627.61OT-R antagonist 2
CAS:OT-R antagonist 2 is a nonpeptide low molecular weight antagonist of OT-R .Formula:C28H29N3O4Purity:98%Color and Shape:SolidMolecular weight:471.55Axelopran
CAS:<p>Axelopran (TD-1211) treats opioid constipation; it's a potent, selective peripheral opioid blocker.</p>Formula:C26H39N3O4Color and Shape:SolidMolecular weight:457.61T4-ATA (S-isomer)
<p>T4-ATA S-isomer, the active form of the thyroid hormone, represents the S-isomer of T4-ATA.</p>Formula:C19H15I4NO6SPurity:98%Color and Shape:SolidMolecular weight:893.01Cgp 38560
CAS:<p>CGP 38560 is a potent renin inhibitor.</p>Formula:C40H67N5O9S2Color and Shape:SolidMolecular weight:826.12Nurr1 agonist 2
CAS:<p>Nurr1 agonist 2 with EC50 of 0.07 μM, boosts TH & VMAT2 mRNA, binds Nurr1 LBD at Kd 0.14 μM, for parkinsonism study.</p>Formula:C18H14O3SPurity:98.78%Color and Shape:SoildMolecular weight:310.37Biphalin TFA
CAS:<p>Biphalin TFA is an opioid peptide analog that penetrates the blood-brain barrier (BBB) and encompasses two active enkephalin pharmacophores.</p>Formula:C46H56N10O10·xC2HF3O2Purity:98%Color and Shape:SolidMolecular weight:909.00 (free base)PTP1B/AKR1B1-IN-1
<p>PTP1B/AKR1B1-IN-1 is a dual inhibitor targeting protein tyrosine phosphatase 1B (PTP1B) and aldose reductase (AKR1B1), exhibiting inhibitory potency with IC50s</p>Formula:C22H21NO4S2Purity:98%Color and Shape:SolidMolecular weight:427.54SL910102
CAS:<p>SL910102 is a nonpeptide angiotensin antagonist of the AT1 receptor.</p>Formula:C30H30N6OPurity:98%Color and Shape:SolidMolecular weight:490.60BWA-6047
<p>BWA-6047 is a dual AR/AR-V7 and GSPT1 PROTAC-type degrader (AR: DC50= 3.7 nM; AR-V7: DC50= 3.0 nM; GSPT1: DC50= 1.2 nM). It facilitates the ubiquitination and degradation of AR/AR-V7 and, through molecular glue properties, induces a PPI between GSPT1 and CRBN, leading to GSPT1 degradation. BWA-6047 is applicable in prostate cancer research.</p>Formula:C42H46ClN5O7Color and Shape:SolidMolecular weight:767.30858[Sar1, Ile8]-Angiotensin II TFA
[Sar1,Ile8]-Angiotensin II (TFA) contracts arteries and affects cell growth in vascular muscle.Formula:C48H74F3N13O12Purity:98%Color and Shape:SolidMolecular weight:1082.18Antihypertensive agent 3
<p>Antihypertensive agent 3 (compound 4a), an angiotensin II receptor 1 antagonist, demonstrates antihypertensive activity in spontaneously hypertensive rats (SHRs</p>Formula:C16H13NO4SColor and Shape:SolidMolecular weight:315.34
